Peptide compositions and their use in particular in the preparation of pharmaceutical compositions active against the hepatitis C virus

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8293528
APP PUB NO 20110020398A1
SERIAL NO

12653751

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention relates to peptide compositions for use in the preparation of pharmaceutical compositions against hepatitis C virus, as well as corresponding methods.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
TRANSGENE SA400 BOULEVARD GONTHIER D'ANDERNACH PARC D'INNOVATION - CS80166 ILLKIRCH-GRAFFENSTADEN 67405

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Fournillier, Anne Lyons, FR 12 35
Himoudi, Nourredine Lyons, FR 5 13
Inchauspe, Geneviève Lyons, FR 8 18
Martin, Perrine Decines Charpieu, FR 11 24

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Apr 23, 2024
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00